A case of fulminant Goodpasture syndrome following alemtuzumab treatment for multiple sclerosis

被引：0
|
作者：
Lapointe, E. [1 ]
Moghaddam, B. [2 ]
Barclay, K. [1 ]
Neufeld, P. [3 ]
Phelps, R. [4 ,5 ]
Traboulsee, A. [1 ]
机构：
[1] Univ British Columbia, Neurol, Vancouver, BC, Canada
[2] Univ British Columbia, Internal Med, Vancouver, BC, Canada
[3] Univ British Columbia, Nephrol, Vancouver, BC, Canada
[4] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[5] Edinburgh Royal Infirm, Edinburgh, Midlothian, Scotland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1207
引用
收藏
页码：640 / 640
页数：1
相关论文
共 50 条
  • [41] Primary Central Nervous System Vasculitis Following Alemtuzumab Treatment for Multiple Sclerosis A Case Report and Literature Review
    Varela, Lucia
    Pappolla, Agustin
    Heriz, Alejandra
    Marquez, Rocio
    Vega, Otto
    Christiansen, Silvia
    Rugiero, Marcelo
    Midaglia, Luciana
    Salerno, Annalaura
    Tintore, Mar
    Rovira, Alex
    NEUROLOGIST, 2023, 28 (04) : 270 - 272
  • [42] First reported case of aquired hemophilia A (AHA) as secondary autoimmune disease following alemtuzumab treatment in multiple sclerosis
    Moiola, L.
    Pisa, M.
    D'Angelo, A.
    Martinelli, V.
    Comi, G.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 379 - 380
  • [43] First reported case of Aquired Hemophilia A (AHA) as secondary autoimmune disease following alemtuzumab treatment in multiple sclerosis
    Pisa, M.
    Moiola, L.
    D'angelo, A.
    Martinelli, V.
    Comi, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 404 - 404
  • [44] EMA approves alemtuzumab for the treatment of multiple sclerosis
    Wilkinson, Jonathan
    IMMUNOTHERAPY, 2013, 5 (11) : 1166 - 1166
  • [45] Alemtuzumab: a further option for treatment of multiple sclerosis
    Menge, T.
    Kieseier, B. C.
    Warnke, C.
    Aktas, O.
    Hartung, H. -P.
    NERVENARZT, 2012, 83 (04): : 487 - 501
  • [46] An observational study of alemtuzumab following fingolimod for multiple sclerosis
    Willis, Mark
    Pearson, Owen
    Illes, Zsolt
    Sejbaek, Tobias
    Nielsen, Christian
    Duddy, Martin
    Petheram, Kate
    van Munster, Caspar
    Killestein, Joep
    Malmestrom, Clas
    Tallantyre, Emma
    Robertson, Neil
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2017, 4 (02):
  • [47] Myasthenia gravis following alemtuzumab therapy for multiple sclerosis
    Midaglia, Luciana
    Gratacos, Margarida
    Caronna, Edoardo
    Raguer, Nuria
    Sastre-Garriga, Jaume
    Montalban, Xavier
    Tintore, Mar
    NEUROLOGY, 2018, 91 (13) : 622 - 624
  • [48] Atypical acute motor axonal neuropathy following alemtuzumab treatment in multiple sclerosis patient
    Hradilek, Pavel
    Woznicova, I.
    Slonkova, J.
    Lochmanova, A.
    Zeman, D.
    ACTA NEUROLOGICA BELGICA, 2017, 117 (04) : 965 - 967
  • [49] Two case reports of acquired haemophilia A as complications of alemtuzumab treatment for multiple sclerosis
    Gounder, Kuhilan
    Batt, Tracey
    Dreyer, Michael
    BMJ NEUROLOGY OPEN, 2021, 3 (01)
  • [50] Atypical acute motor axonal neuropathy following alemtuzumab treatment in multiple sclerosis patient
    Pavel Hradilek
    I. Woznicova
    J. Slonkova
    A. Lochmanova
    D. Zeman
    Acta Neurologica Belgica, 2017, 117 : 965 - 967
12345